Anna Kamińska

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy

Giulia Barcia, Matthew R. Fleming, Aline Deligniere et al. · Nature Genetics · 2012 · 517 citations · Full text

Developmental Biology, Hyperpolarization (Biology), Ion Channels +5

Lamotrigine and Seizure Aggravation in Severe Myoclonic Epilepsy

Renzo Guerrini, Charlotte Dravet, Pierre Genton et al. · Epilepsia · 1998 · 458 citations

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

Disease Progression, Neurological Disorder, Immunology +8

Rapid Cortical Oscillations and Early Motor Activity in Premature Human Neonate

Mathieu Milh, Anna Kamińska, Catherine Huon et al. · Cerebral Cortex · 2006 · 322 citations · Full text